Platelets in inflammatory bowel disease

Clinical, pathogenic, and therapeutic implications

Silvio Danese, Carol De La Motte, Claudio Fiocchi

Research output: Contribution to journalArticle

166 Citations (Scopus)

Abstract

Both Crohn's disease (CD) and ulcerative colitis (UC) are associated with abnormalities of platelet number and function. In the peripheral circulation the state of platelet activation is typically increased, and inflammatory bowel disease (IBD)-involved mucosa frequently contains platelet aggregates within mucosal microthrombi. The relevance of platelet dysfunction to IBD pathogenesis is still unclear, but there is solid evidence demonstrating that platelets, in addition to their traditional role in hemostasis, can also function as potent proinflammatory cells. Upon activation, platelets secrete a large number of biologically active molecules able to induce or amplify an inflammatory process through many of the same cellular and molecular pathways conventionally utilized by immune cells mediating IBD. The aim of this article is to review data on the existence of platelet dysfunction in IBD, substantiate platelets' inflammatory potential, discuss the implications of abnormal platelet activity for chronic intestinal inflammation, and consider the potential benefits of platelet modulation for treatment of IBD.

Original languageEnglish
Pages (from-to)938-945
Number of pages8
JournalAmerican Journal of Gastroenterology
Volume99
Issue number5
DOIs
Publication statusPublished - May 2004

Fingerprint

Inflammatory Bowel Diseases
Blood Platelets
Therapeutics
Platelet Activation
Hemostasis
Platelet Count
Ulcerative Colitis
Crohn Disease
Mucous Membrane
Inflammation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Platelets in inflammatory bowel disease : Clinical, pathogenic, and therapeutic implications. / Danese, Silvio; De La Motte, Carol; Fiocchi, Claudio.

In: American Journal of Gastroenterology, Vol. 99, No. 5, 05.2004, p. 938-945.

Research output: Contribution to journalArticle

@article{9e5d2592294f48bda457569feecc8345,
title = "Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications",
abstract = "Both Crohn's disease (CD) and ulcerative colitis (UC) are associated with abnormalities of platelet number and function. In the peripheral circulation the state of platelet activation is typically increased, and inflammatory bowel disease (IBD)-involved mucosa frequently contains platelet aggregates within mucosal microthrombi. The relevance of platelet dysfunction to IBD pathogenesis is still unclear, but there is solid evidence demonstrating that platelets, in addition to their traditional role in hemostasis, can also function as potent proinflammatory cells. Upon activation, platelets secrete a large number of biologically active molecules able to induce or amplify an inflammatory process through many of the same cellular and molecular pathways conventionally utilized by immune cells mediating IBD. The aim of this article is to review data on the existence of platelet dysfunction in IBD, substantiate platelets' inflammatory potential, discuss the implications of abnormal platelet activity for chronic intestinal inflammation, and consider the potential benefits of platelet modulation for treatment of IBD.",
author = "Silvio Danese and {De La Motte}, Carol and Claudio Fiocchi",
year = "2004",
month = "5",
doi = "10.1111/j.1572-0241.2004.04129.x",
language = "English",
volume = "99",
pages = "938--945",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Platelets in inflammatory bowel disease

T2 - Clinical, pathogenic, and therapeutic implications

AU - Danese, Silvio

AU - De La Motte, Carol

AU - Fiocchi, Claudio

PY - 2004/5

Y1 - 2004/5

N2 - Both Crohn's disease (CD) and ulcerative colitis (UC) are associated with abnormalities of platelet number and function. In the peripheral circulation the state of platelet activation is typically increased, and inflammatory bowel disease (IBD)-involved mucosa frequently contains platelet aggregates within mucosal microthrombi. The relevance of platelet dysfunction to IBD pathogenesis is still unclear, but there is solid evidence demonstrating that platelets, in addition to their traditional role in hemostasis, can also function as potent proinflammatory cells. Upon activation, platelets secrete a large number of biologically active molecules able to induce or amplify an inflammatory process through many of the same cellular and molecular pathways conventionally utilized by immune cells mediating IBD. The aim of this article is to review data on the existence of platelet dysfunction in IBD, substantiate platelets' inflammatory potential, discuss the implications of abnormal platelet activity for chronic intestinal inflammation, and consider the potential benefits of platelet modulation for treatment of IBD.

AB - Both Crohn's disease (CD) and ulcerative colitis (UC) are associated with abnormalities of platelet number and function. In the peripheral circulation the state of platelet activation is typically increased, and inflammatory bowel disease (IBD)-involved mucosa frequently contains platelet aggregates within mucosal microthrombi. The relevance of platelet dysfunction to IBD pathogenesis is still unclear, but there is solid evidence demonstrating that platelets, in addition to their traditional role in hemostasis, can also function as potent proinflammatory cells. Upon activation, platelets secrete a large number of biologically active molecules able to induce or amplify an inflammatory process through many of the same cellular and molecular pathways conventionally utilized by immune cells mediating IBD. The aim of this article is to review data on the existence of platelet dysfunction in IBD, substantiate platelets' inflammatory potential, discuss the implications of abnormal platelet activity for chronic intestinal inflammation, and consider the potential benefits of platelet modulation for treatment of IBD.

UR - http://www.scopus.com/inward/record.url?scp=2942666368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942666368&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2004.04129.x

DO - 10.1111/j.1572-0241.2004.04129.x

M3 - Article

VL - 99

SP - 938

EP - 945

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 5

ER -